RGTHealth CareCompany Update29 Sept 202629 September 2026· 2 min read
Argent BioPharma (ASX: RGT) Licences NLC Antiviral Portfolio
Argent BioPharma has licensed commercial rights to NLC’s Tollovir, Tollovid and NutraVir antiviral applications. The deal includes US$300,000 in scheduled base fees, tiered royalties and sales-linked consideration.